```html

Cholangitis: A Complete Patient‑Friendly Guide

Overview

Cholangitis is an infection or inflammation of the bile ducts—the channels that carry bile from the liver to the gallbladder and small intestine. The most common form is acute cholangitis, also known as ascending cholangitis, which typically occurs when a blockage (often a gallstone) allows bacteria to ascend from the intestine into the biliary tree.

Who it affects

• Adults > 50 years old are most frequently diagnosed, but children can develop cholangitis in the setting of congenital biliary anomalies.
• Both sexes are affected; slight male predominance is reported in some population studies.
• People with a history of gallstones, biliary strictures, or previous endoscopic procedures are at higher risk.

Prevalence

• In the United States, acute cholangitis accounts for roughly 10–15 % of all cases of acute biliary disease, translating to an estimated 30,000–40,000 hospital admissions per year (CDC, 2023).
• Incidence rises in regions with higher rates of gallstone disease, such as East Asia and parts of the Middle East.

Symptoms

Symptoms can develop suddenly (acute) or progress slowly (chronic). Classic “Charcot’s triad” (fever, right‑upper‑quadrant pain, jaundice) describes acute cholangitis; a fourth feature—hypotension or altered mental status—forms “Reynolds’ pentad,” indicating severe disease.

Common presenting features

• Fever & chills – often high‑grade, may be intermittent.
• Right‑upper‑quadrant (RUQ) abdominal pain – described as a steady, deep ache; can radiate to the back or right shoulder.
• Jaundice – yellowing of the skin and whites of the eyes; may be accompanied by dark urine and pale stools.
• Pruritus (itching) – caused by bile salts deposited in the skin.
• Nausea & vomiting – especially with severe pain.
• General malaise, fatigue.

Signs of severe (ascending) cholangitis (Reynolds’ pentad)

• Hypotension (systolic < 90 mmHg) or shock.
• Altered mental status (confusion, lethargy).
• Rapid heart rate (tachycardia).
• Laboratory evidence of organ dysfunction (elevated creatinine, coagulopathy).

Causes and Risk Factors

Primary causes

• Gallstones (choledocholithiasis) – the most frequent obstructive cause.
• Benign biliary strictures – from prior surgery, chronic pancreatitis, or inflammatory diseases.
• Malignant obstruction – pancreatic head cancer, cholangiocarcinoma, gallbladder carcinoma.
• Parasites – e.g., Clonorchis sinensis in endemic Asian regions.
• Endoscopic procedures – ERCP (endoscopic retrograde cholangiopancreatography) can introduce bacteria.

Risk factors

• Age > 50 years.
• History of gallstones or prior biliary surgery.
• Chronic liver disease (cirrhosis, primary sclerosing cholangitis).
• Immunosuppression (diabetes, HIV, steroid use).
• Pregnancy – hormonal changes can promote gallstone formation.
• Obesity & high‑fat diet – increase gallstone risk.

Diagnosis

Clinical assessment

Physicians first look for Charcot’s triad and assess vitals for signs of sepsis. A thorough history (prior gallstones, surgeries, recent ERCP) guides further work‑up.

Laboratory tests

• Complete blood count – leukocytosis indicates infection.
• Liver function panel – elevated alkaline phosphatase (ALP), γ‑glutamyl transferase (GGT), bilirubin, and transaminases.
• Blood cultures – positive in 30–50 % of severe cases.
• Inflammatory markers – C‑reactive protein (CRP) or procalcitonin can gauge severity.

Imaging studies

• Ultrasound – first‑line; shows biliary dilation, stones, or sludge.
• Magnetic Resonance Cholangiopancreatography (MRCP) – non‑invasive, provides detailed bile‑duct anatomy.
• Endoscopic Retrograde Cholangiopancreatography (ERCP) – both diagnostic and therapeutic; gold standard for relieving obstruction.
• CT scan – helpful in detecting complications such as liver abscess or emphysematous cholangitis.

Severity scoring

Many clinicians use the Tokyo Guidelines 2018 to stratify patients into mild, moderate, or severe disease based on clinical, laboratory, and imaging criteria, guiding treatment intensity.

Treatment Options

Initial emergency management (within the first few hours)

1. Intravenous broad‑spectrum antibiotics – e.g., ceftriaxone + metronidazole or piperacillin‑tazobactam. Adjust once cultures return.
2. Fluid resuscitation – isotonic crystalloids to maintain blood pressure.
3. Analgesia – judicious use of opioids or non‑opioid agents for pain control.

Definitive biliary drainage

• ERCP with sphincterotomy and stone extraction – preferred for most patients; success > 90 %.
• Percutaneous transhepatic biliary drainage (PTBD) – used when ERCP is unsuccessful or contraindicated.
• Surgical options – open or laparoscopic common bile duct exploration, choledochoduodenostomy, or biliary bypass in selected cases.

Adjunctive therapies

• Ursodeoxycholic acid (UDCA) – may be prescribed after acute episode for patients with chronic biliary disease.
• Probiotics – emerging evidence suggests they may reduce bacterial translocation, though not yet standard of care.

Long‑term management

• Address underlying cause (e.g., cholecystectomy for gallstones).
• Regular imaging surveillance if strictures or malignancy are present.
• Vaccination against hepatitis A & B to protect a compromised liver.

Living with Cholangitis

Daily management tips

• Medication adherence – complete full antibiotic courses even if symptoms improve.
• Hydration – aim for at least 2 L of water daily unless fluid‑restricted.
• Dietary considerations – low‑fat, high‑fiber diet reduces gallstone formation; avoid rapid weight loss diets.
• Weight control – maintain a healthy BMI (18.5–24.9 kg/m²).
• Monitor for warning signs – keep a symptom diary; call your clinician if pain recurs, jaundice returns, or fevers develop.
• Follow‑up appointments – typically within 1–2 weeks after discharge, then every 3–6 months depending on underlying cause.

Support resources

• American Liver Foundation (www.liverfoundation.org) – patient education and support groups.
• Local dietitian familiar with biliary disease.
• Online forums (e.g., Reddit r/liver) – useful for peer experiences, but always verify advice with your provider.

Prevention

• Prevent gallstone formation – eat a balanced diet rich in fruits, vegetables, whole grains; limit saturated fats and cholesterol.
• Maintain regular physical activity – at least 150 minutes of moderate aerobic exercise per week.
• Avoid rapid weight loss – losing > 1–2 kg per week can precipitate gallstones.
• Control diabetes and hyperlipidemia – proper medication and lifestyle measures lower stone risk.
• Prompt treatment of biliary infections – seek care early for any abdominal pain or jaundice.
• Vaccinations – hepatitis A and B protect the liver in case of future insults.

Complications

If untreated or delayed, cholangitis can progress to life‑threatening conditions:

• Septic shock – systemic infection leading to organ failure.
• Liver abscess – collection of pus within hepatic tissue.
• Acute renal failure – due to hypotension and toxin build‑up.
• Coagulopathy – impaired clotting from liver dysfunction.
• Chronic biliary strictures – may require long‑term stenting.
• Secondary biliary cirrhosis – long‑standing obstruction causing fibrosis.
• Increased mortality – severe (Reynolds’ pentad) cholangitis carries a 30‑50 % mortality rate without rapid intervention (Mayo Clinic, 2022).

When to Seek Emergency Care

---

**References** (consulted up to May 2026)

• Mayo Clinic. “Acute cholangitis.” 2023. Link
• Tokyo Guidelines 2018 for the Management of Acute Cholangiitis and Cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):96‑112.
• CDC. “Gallstone disease & related complications.” 2023. Link
• American College of Gastroenterology. “Guideline: Endoscopic Management of Biliary Disease.” 2022.
• NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Biliary Tract Diseases.” 2021.
• Cleveland Clinic. “Cholangitis – Symptoms, Diagnosis, Treatment.” 2024.

```